- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Tolebrutinib is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- L04AA62 Tolebrutinib · Immunosuppressive drug, subgroup L04AA
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII 8CZ82ZYY9XCAS 1971920-73-6DrugBank DB18715Q130337251
All presentations
No presentations of Tolebrutinib are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Tolebrutinib available for export from India?
No presentation of Tolebrutinib is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Tolebrutinib authorised in the European Union?
Yes. Tolebrutinib has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Tolebrutinib need cold chain shipping?
No listed presentation of Tolebrutinib is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Tolebrutinib in?
Tolebrutinib is classified under ATC code L04AA62 (Tolebrutinib).
References
- Cenrifki: European public assessment report (EPAR). European Medicines Agency. Retrieved 7 October 2026
Request Tolebrutinib for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.